Observational studyCancer control : journal of the Moffitt Cancer Center

Integrative Molecular Analysis to Predict Clinical Benefit of Everolimus in Patients With Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP-NETs).

Miran Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.